For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it should instead lift the burden of certain tasks to make for more patient visits.
|Articles|February 18, 2022
Poll results: What percentage of CE hours should ODs be able to take online?
Author(s)Brooke Henson, Editor
See our latest poll results
Advertisement
Optometry Times® polled our audience with the following question from December 3, 2021 to December 17, 2021:
The poll appeared on
13 ODs responded, in total. Of these:
- 0 responded "0%"
- 1 responded "Up to 25%"
- 1 responded "Up to 50%"
- 3 responded "Up to 75%"
- 8 responded "100%"
Advertisement
Related to this article
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs fell for the first time since tracking began.
Maria Sampalis, OD, discusses her implementation of the EHR software Barti in her practice.
To kick off Perimenopause and Menopause Awareness Month, Meredith Bishop, OD, MS, FAAO, gives an overview of her poster "Perceptions of Linking Presbyopia with Perimenopause: A Survey of US Female Eye Care Professionals."
FDA advisers review SYD-101, low-dose atropine 0.01% for pediatric myopia, on Oct 30 after a 2025 complete response letter.
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what he hopes to see in 2027.
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.
Christina M. Danley, OD, FOVDR, explores the many nuances that require consideration when answering a common question asked by parents of children with myopia.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
The screen time question: What to ask and when to look deeper
2
AAOpt 2026: Current controversies in macular hole diagnosis, management
3
AAOpt 2026: Jeffrey Walline, OD, PhD, on his conference takeaways
4
FAQ: What clinicians should know as SYD-101 heads to FDA advisory committee
5